Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Varani

Showing results (171-180 of 239) with videos related to

Pageof 24
Sort By:
Archiv Der Pharmazie|September 26, 2023
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agentsAlessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry|May 28, 2011
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonistsOmbretta Lenzi, Vittoria Colotta, Daniela Catarzi, et al.
Bioorganic & Medicinal Chemistry|February 20, 2007
N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptorPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Brain Stimulation|February 23, 2013
A consensus panel review of central nervous system effects of the exposure to low-intensity extremely low-frequency magnetic fieldsVincenzo Di Lazzaro, Fioravante Capone, Francesca Apollonio, et al.
Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
European Journal of Medicinal Chemistry|July 5, 2015
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect studyRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez-Cara, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptorsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Bioorganic & Medicinal Chemistry|November 23, 2012
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studiesDaniela Catarzi, Vittoria Colotta, Flavia Varano, et al.
Translational Psychiatry|February 6, 2021
Adenosine A<sub>2A</sub> receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO miceAntonella Ferrante, Zaira Boussadia, Antonella Borreca, et al.
Pageof 24

Showing results (171-180 of 239) with videos related to

Sort By:
Pageof 24
Archiv Der Pharmazie|September 26, 2023
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agentsAlessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Journal of Medicinal Chemistry|March 21, 2003
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonistsPier Giovanni Baraldi, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry|May 28, 2011
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonistsOmbretta Lenzi, Vittoria Colotta, Daniela Catarzi, et al.
Bioorganic & Medicinal Chemistry|February 20, 2007
N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptorPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Brain Stimulation|February 23, 2013
A consensus panel review of central nervous system effects of the exposure to low-intensity extremely low-frequency magnetic fieldsVincenzo Di Lazzaro, Fioravante Capone, Francesca Apollonio, et al.
Journal of Medicinal Chemistry|January 29, 2013
Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
European Journal of Medicinal Chemistry|July 5, 2015
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect studyRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez-Cara, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptorsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
Bioorganic & Medicinal Chemistry|November 23, 2012
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studiesDaniela Catarzi, Vittoria Colotta, Flavia Varano, et al.
Translational Psychiatry|February 6, 2021
Adenosine A<sub>2A</sub> receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO miceAntonella Ferrante, Zaira Boussadia, Antonella Borreca, et al.
Pageof 24